Biotechnology: Biological Products (No Diagnostic Substances)

Management ChangeApr 27, 2026, 08:12 AM

EVAX Promotes Birgitte Rønø to Chief Scientific and COO

AI Summary

Evaxion A/S, a clinical-stage TechBio company, announced the promotion of Birgitte Rønø to the combined position of Chief Scientific and Chief Operating Officer. This strategic leadership change aims to leverage Rønø's expertise across both scientific development and operational management.

Key Highlights

Evaxion A/S promoted Birgitte Rønø to the joint role of Chief Scientific and Chief Operating Officer.

View SEC Filing

EVAX

Biotechnology: Biological Products (No Diagnostic Substances)

Evaxion A/S

Price Impact